Rocket Lab Price Targets Are Falling, but We’re Making Another Trade Today
Our repair work continues on the $10,000 Portfolio.
Our repair work continues on the $10,000 Portfolio.
Four buys, one sale and one exit as we fight back and right the ship.
We sold some of our position in the aerospace firm alongside ARK Invest.
Our small-cap portfolio is reeling a bit.
We’re buying more shares after a harsh day for the position.
Ocular Therapeutix is selling off sharply, taking our small-cap portfolio down with it.
The news likely helped push the major space stocks higher.
PSKY has not sold off as I expected it to.
The financial services firm announced a major crypto agreement with Mastercard.